Focus: Demystifying how Glassbury AI structures data, paired with the industry's shift from symptom-based diagnosis to multi-omic reality.

The biggest breakthrough shaking up the medical community is the arrival of ultra-precise blood-based biomarkers (like the pTau217 test). Scientists can now detect microscopic traces of Alzheimer’s proteins floating right in your bloodstream.